These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8466163

  • 1. Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome.
    Spencer K, Wood PJ, Anthony FW.
    Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():219-20. PubMed ID: 8466163
    [No Abstract] [Full Text] [Related]

  • 2. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Wallace EM, Swanston IA, McNeilly AS, Ashby JP, Blundell G, Calder AA, Groome NP.
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):17-21. PubMed ID: 8706288
    [Abstract] [Full Text] [Related]

  • 3. Maternal serum dimeric inhibin A in second-trimester Down's syndrome pregnancies.
    Cuckle HS, Holding S, Jones R, Wallace EM, Groome NP.
    Prenat Diagn; 1995 Apr; 15(4):385-6. PubMed ID: 7617583
    [No Abstract] [Full Text] [Related]

  • 4. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA, Wallace EM, Crossley JA, Swanston IA, van Pareren Y, van Maarle M, Groome NP, Macri JN, Connor JM.
    N Engl J Med; 1996 May 09; 334(19):1231-6. PubMed ID: 8606718
    [Abstract] [Full Text] [Related]

  • 5. Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome.
    Van Lith JM, Pratt JJ, Beekhuis JR, Mantingh A.
    Prenat Diagn; 1992 Oct 09; 12(10):801-6. PubMed ID: 1475248
    [Abstract] [Full Text] [Related]

  • 6. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
    Lambert-Messerlian GM, Canick JA, Palomaki GE, Schneyer AL.
    J Med Screen; 1996 Oct 09; 3(2):58-62. PubMed ID: 8849760
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome.
    Wallace EM, Harkness LM, Burns S, Liston WA.
    Clin Endocrinol (Oxf); 1994 Oct 09; 41(4):483-6. PubMed ID: 7955459
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of maternal serum dimeric inhibin A as a first-trimester marker of Down's syndrome.
    Wallace EM, Grant VE, Swanston IA, Groome NP.
    Prenat Diagn; 1995 Apr 09; 15(4):359-62. PubMed ID: 7617577
    [Abstract] [Full Text] [Related]

  • 9. Second trimester maternal serum ADAM12 levels in Down's syndrome pregnancies.
    Donalson K, Turner S, Wastell H, Cuckle H.
    Prenat Diagn; 2008 Oct 09; 28(10):904-7. PubMed ID: 18785180
    [Abstract] [Full Text] [Related]

  • 10. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies.
    Cuckle HS, Holding S, Jones R.
    Prenat Diagn; 1994 May 09; 14(5):387-90. PubMed ID: 7521963
    [Abstract] [Full Text] [Related]

  • 11. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE, Palomaki GE, Knight GJ, Foster DL, Neveux LM.
    J Med Screen; 1998 May 09; 5(3):115-9. PubMed ID: 9795869
    [Abstract] [Full Text] [Related]

  • 12. Stability of inhibin A and unconjugated oestriol in the second trimester of pregnancy.
    Brown LF, Shearing CH, Tydeman G.
    Ann Clin Biochem; 2011 Jan 09; 48(Pt 1):72-4. PubMed ID: 21115569
    [Abstract] [Full Text] [Related]

  • 13. Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening.
    Knight GJ, Palomaki GE, Neveux LM, Haddow JE, Lambert-Messerlian GM.
    J Med Screen; 2001 Jan 09; 8(1):2-7. PubMed ID: 11373844
    [Abstract] [Full Text] [Related]

  • 14. SURUSS in perspective.
    Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A.
    Semin Perinatol; 2005 Aug 09; 29(4):225-35. PubMed ID: 16104673
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
    Wald NJ, Watt HC, Hackshaw AK.
    N Engl J Med; 1999 Aug 12; 341(7):461-7. PubMed ID: 10441601
    [Abstract] [Full Text] [Related]

  • 18. Effect of smoking status on inhibin-A in second-trimester prenatal screening for Down syndrome.
    Huttly W, Bestwick J, Wald N.
    Prenat Diagn; 2014 Apr 12; 34(4):406-7. PubMed ID: 24395085
    [No Abstract] [Full Text] [Related]

  • 19. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].
    Yu DY, Fu P, Zhang ZH, Wang F, Han MY, Ren HY, Zhao W, Zhang K, Li S, Jiang N.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun 12; 28(3):332-5. PubMed ID: 21644235
    [Abstract] [Full Text] [Related]

  • 20. First-trimester or second-trimester screening, or both, for Down's syndrome.
    Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME, First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium.
    N Engl J Med; 2005 Nov 10; 353(19):2001-11. PubMed ID: 16282175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.